TAO Dan, GONG Wei, QIN Songbing, XU Xiaoting, ZHOU Juying, WANG Lili. Value of perioperative carcinoembryonic antigen combined with carbohydrate antigen 19-9 and carbohydrate antigen 125 in predicting prognosis of patients with colorectal cancer in stages Ⅰ to Ⅲ[J]. Journal of Clinical Medicine in Practice, 2021, 25(9): 46-51. DOI: 10.7619/jcmp.20210560
Citation: TAO Dan, GONG Wei, QIN Songbing, XU Xiaoting, ZHOU Juying, WANG Lili. Value of perioperative carcinoembryonic antigen combined with carbohydrate antigen 19-9 and carbohydrate antigen 125 in predicting prognosis of patients with colorectal cancer in stages Ⅰ to Ⅲ[J]. Journal of Clinical Medicine in Practice, 2021, 25(9): 46-51. DOI: 10.7619/jcmp.20210560

Value of perioperative carcinoembryonic antigen combined with carbohydrate antigen 19-9 and carbohydrate antigen 125 in predicting prognosis of patients with colorectal cancer in stages Ⅰ to Ⅲ

More Information
  • Received Date: January 30, 2021
  • Available Online: April 28, 2021
  • Published Date: May 14, 2021
  •   Objective  To explore the relationship between the change of perioperative carcinoembryonic antigen (CEA) level and clinical features, disease progression in patients with stage Ⅰ to Ⅲ colorectal cancer, and to analyze the values of postoperative carbohydrate antigen 125 (CA125) and carbohydrate antigen 19-9 (CA19-9) in evaluating prognosis of patients with postoperative CEA negative result.
      Methods  Totally 287 patients with radical operation for colorectal cancer from January 2013 to December 2016 in the First Hospital Affiliated to Soochow University were selected. Chi-square test, Kaplan-Meier method, Log-rank test, and Cox risk regression model were used to analyze the relationships between the perioperative CEA, combination of postoperative CA125 and CA19-9 and clinical pathological characteristics and prognosis.
      Results  The median follow-up time was 49 months. Postoperative CEA positive was significantly correlated with adverse T stage (T3, T4), N stage (N1, N2) and TNM stage (P < 0.01), and was significantly correlated with cancer nodule and nerve invasion (P < 0.05). Univariate analysis showed that N stage, TNM stage, tumor differentiation, tumor nodule, vascular tumor thrombus, nerve invasion, CA19-9 and CA125 were the related factors affecting disease free survival (DFS) (P < 0.05), and N stage, tumor differentiation, tumor nodule, CA19-9 and CA724 were the related factors affecting overall survival (OS) (P < 0.05). Multivariate analysis showed that postoperative CA125 positive (P < 0.001) and tumor nodule (P < 0.05) were independent prognostic factors for DFS in patients with CEA negative. Tumor nodule (P < 0.05) and tumor differentiation (P < 0.05) were important factors affecting OS. The DFS and OS of patients with both preoperative and postoperative CEA negative were significantly higher than those of patients with preoperative or postoperative CEA positive, the DFS and OS of patients with postoperative CEA returning to normal were significantly higher than those of patients without postoperative CEA returning to normal, and the DFS and OS of patients with both postoperative CA19-9 and CA125 negative were higher than those of patients with postoperative CA19-9 or CA125 positive (P < 0.05 or P < 0.01).
      Conclusion  The change of serum CEA level in perioperative period can directly affect the prognosis of CRC patients, and the prognosis of patients with both preoperative and postoperative CEA negative or CEA decreasing to normal level in the early postoperative period are better. For patients with CEA negative after operation, the positive expression of CA125 or CA19-9 after operation indicates that the risks of recurrence and metastasis are increasing, and the prognosis is poor.
  • [1]
    BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
    [2]
    郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005
    [3]
    STRACCI F, ZORZI M, GRAZZINI G. Colorectal cancer screening: tests, strategies, and perspectives[J]. Front Public Health, 2014, 2: 210. http://europepmc.org/articles/PMC4209818
    [4]
    SAITO G, SADAHIRO S, KAMATA H, et al. Monitoring of serum carcinoembryonic antigen levels after curative resection of colon cancer: cutoff values determined according to preoperative levels enhance the diagnostic accuracy for recurrence[J]. Oncology, 2017, 92(5): 276-282. doi: 10.1159/000456075
    [5]
    RAMPHAL W, BOEDING J R E, VAN IWAARDEN M, et al. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer[J]. Int J Biol Markers, 2019, 34(1): 60-68. doi: 10.1177/1724600818820679
    [6]
    LIN P C, LIN J K, LIN C C, et al. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis[J]. Int J Colorectal Dis, 2012, 27(10): 1333-1338. doi: 10.1007/s00384-012-1447-1
    [7]
    LI Q, DAI W, LI Y, et al. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection[J]. Sci Rep, 2017, 7: 46345. doi: 10.1038/srep46345
    [8]
    ZHONG W, YU Z, ZHAN J, et al. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer[J]. Pathol Oncol Res, 2015, 21(1): 83-95. doi: 10.1007/s12253-014-9791-9
    [9]
    GUNAWARDENE A, LARSEN P, SHEKOUH A, et al. Pre-operative carcinoembryonic antigen predicts survival following colorectal cancer surgery with curative intent[J]. ANZ J Surg, 2018, 88(12): 1311-1315. doi: 10.1111/ans.14723
    [10]
    BHATTI I, PATEL M, DENNISON A R, et al. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer[J]. Int J Surg, 2015, 16(Pt A): 123-128. http://www.ncbi.nlm.nih.gov/pubmed/25771102
    [11]
    SØRENSEN C G, KARLSSON W K, POMMERGAARD H C, et al. The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence-A systematic review[J]. Int J Surg, 2016, 25: 134-144. http://www.sciencedirect.com/science/article/pii/S1743919115013953
    [12]
    LIN J K, LIN C C, YANG S H, et al. Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer[J]. Int J Colorectal Dis, 2011, 26(9): 1135-1141. doi: 10.1007/s00384-011-1209-5
    [13]
    KONISHI T, SHIMADA Y, HSU M, et al. Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome[J]. JAMA Oncol, 2018, 4(3): 309-315. doi: 10.1001/jamaoncol.2017.4420
    [14]
    SHIBUTANI M, MAEDA K, NAGAHARA H, et al. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage Ⅱ colorectal cancer[J]. Anticancer Res, 2014, 34(7): 3753-3758. http://europepmc.org/abstract/MED/24982398
    [15]
    USHIGOME M, SHIMADA H, MIURA Y, et al. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA[J]. Int J Clin Oncol, 2020, 25(4): 622-632. doi: 10.1007/s10147-019-01597-6
    [16]
    SCARÁS, BOTTONI P, SCATENA R. CA 19-9: biochemical and clinical aspects[J]. Adv Exp Med Biol, 2015, 867: 247-260. doi: 10.1007/978-94-017-7215-0_15
    [17]
    ZHOU W H, YANG F, PENG J H, et al. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage Ⅲcolon cancer after curative resection and adjuvant chemotherapy[J]. J Cancer, 2019, 10(16): 3810-3818. doi: 10.7150/jca.31375
    [18]
    TOKODAI K, NARIMATSU H, NISHIDA A, et al. Risk factors for recurrence in stage Ⅱ/Ⅲcolorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern[J]. J Surg Oncol, 2016, 114(3): 368-374. doi: 10.1002/jso.24320
    [19]
    YANG X Q, LI Y, CHEN C, et al. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer[J]. Med Oncol, 2011, 28(3): 789-795. doi: 10.1007/s12032-010-9518-z
    [20]
    HUANG S H, TSAI W S, YOU J F, et al. Preoperative carcinoembryonic antigen as a poor prognostic factor in stage Ⅰ~Ⅲcolorectal cancer after curative-intent resection: a propensity score matching analysis[J]. Ann Surg Oncol, 2019, 26(6): 1685-1694. doi: 10.1245/s10434-019-07184-3
    [21]
    HOTTA T, TAKIFUJI K, YOKOYAMA S, et al. Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer[J]. Surg Today, 2014, 44(11): 2106-2115. doi: 10.1007/s00595-014-0852-1
  • Related Articles

    [1]DING Xiaorui, LU Minmin, DONG Hao. Effect and mechanism of N-acetylcysteine on methylnitrosourea-induced precancerous lesions of gastric cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 6-13. DOI: 10.7619/jcmp.20245014
    [2]MOU Yanhui, CHEN Zhaogui, YAO Guang, CHEN Jingci, QUAN Zhi. Mechanism of acupuncture on hippocampal neuron apoptosis in rat model of post-traumatic stress disorder via the reactive oxygen species/c-Jun N-terminal kinase/p53 pathway[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 44-49, 72. DOI: 10.7619/jcmp.20243510
    [3]CUI Xiaojing, ZHAO Chunmei, YANG Bo. Expression and significance of serum insulin-like growth factor binding protein-7 and silencing information regulator 4 in patients with acute heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 74-78, 83. DOI: 10.7619/jcmp.20232118
    [4]YANG Ting, WANG Xiaohong, LI Yi. The clinical efficacy and mechanism of melatonin in the treatment of premature ovarian insufficiency[J]. Journal of Clinical Medicine in Practice, 2023, 27(16): 75-78, 83. DOI: 10.7619/jcmp.20230708
    [5]LI Ning, WU Feng, HU Tao. Research progress of hypoxia-inducible factor-1α and obstructive sleep apnea associated hypertension[J]. Journal of Clinical Medicine in Practice, 2023, 27(7): 138-142. DOI: 10.7619/jcmp.20223407
    [6]LIAO Weizu, JIA Gengpei, YANG Zheng, SUN Yi. Effect and mechanism of oxyhydrogen machine in antifungal adjuvant therapy[J]. Journal of Clinical Medicine in Practice, 2022, 26(20): 16-22. DOI: 10.7619/jcmp.20221558
    [7]PENG Yuan, SHENG Xiao, YE Xinhua, YU Wenlong, XUE Yun, CHENG Jinluo. High glucose stimulates oxidative stress and inflammatory response of glomerular mesangial cells in rats by regulating PINK1/Parkin pathway[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 6-12. DOI: 10.7619/jcmp.20212562
    [8]XU Lei, YANG Lei, WU Fan, YAN Ying, HANG Xiao, YU Duonan. MiR-144/451 suppresses AKT phosphorylation by controlling ROS levels in erythroid cells of rats: A clinical trail study[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 29-32. DOI: 10.7619/jcmp.202002009
    [9]ZHANG Rong, YANG Xinquan, XIONG Ting, TANG Shan, AI Keqing, ZHONG Hongyan, MAO Yongqing, WANG Daxin. GKT137831 alleviates atorvastatin-induced decreased glucose uptake of skeletal muscle by suppressing reactive oxygen species level[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 53-57. DOI: 10.7619/jcmp.201910015
    [10]LIANG Yefei, ZHOU Youwang. Effects of an oxygen free radical scavenger on serum inflammatory factors of patients with acute cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2013, (14): 53-55. DOI: 10.7619/jcmp.201314018

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return